State of Wisconsin Investment Board
BCRX icon

State of Wisconsin Investment Board’s BioCryst Pharmaceuticals BCRX Stock Holding History

State of Wisconsin Investment Board’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.66M Sell
279,064
-68,126
-20% -$529K 0.01% 1296
2025
Q4 		$2.71M Sell
347,190
-28,661
-8% -$207K 0.01% 1288
2025
Q3 		$2.85M Buy
375,851
+602
+0.2% +$5.01K 0.01% 1201
2025
Q2 		$3.36M Sell
375,249
-152,997
-29% -$1.42M 0.01% 1077
2025
Q1 		$3.96M Buy
528,246
+100,964
+24% +$814K 0.01% 1015
2024
Q4 		$3.21M Buy
427,282
+243,354
+132% +$1.85M 0.01% 1122
2024
Q3 		$1.4M Sell
183,928
-49,619
-21% -$377K ﹤0.01% 1451
2024
Q2 		$1.44M Buy
233,547
+96,698
+71% +$534K ﹤0.01% 1424
2024
Q1 		$695K Sell
136,849
-17,912
-12% -$101K ﹤0.01% 1570
2023
Q4 		$927K Sell
154,761
-44,256
-22% -$256K ﹤0.01% 1415
2023
Q3 		$1.41M Sell
199,017
-50,865
-20% -$365K ﹤0.01% 1324
2023
Q2 		$1.76M Buy
249,882
+10,402
+4% +$83.5K ﹤0.01% 1330
2023
Q1 		$2M Buy
239,480
+52,895
+28% +$509K 0.01% 1307
2022
Q4 		$2.14M Sell
186,585
-2,317
-1% -$28.9K 0.01% 1299
2022
Q3 		$2.38M Sell
188,902
-6,998
-4% -$90.1K 0.01% 1299
2022
Q2 		$2.07M Sell
195,900
-41,900
-18% -$432K 0.01% 1351
2022
Q1 		$3.87M Sell
237,800
-21,900
-8% -$351K 0.01% 1263
2021
Q4 		$3.6M Hold
259,700
– – 0.01% 1129
2021
Q3 		$3.73M Hold
259,700
– – 0.01% 1125
2021
Q2 		$4.11M Sell
259,700
-9,200
-3% -$125K 0.01% 1106
2021
Q1 		$2.73M Sell
268,900
-23,100
-8% -$238K 0.01% 1168
2020
Q4 		$2.17M Sell
292,000
-48,900
-14% -$252K 0.01% 1185
2020
Q3 		$1.17M Buy
340,900
+110,100
+48% +$472K ﹤0.01% 1259
2020
Q2 		$1.1M Buy
230,800
+2,200
+1% +$8.79K ﹤0.01% 1225
2020
Q1 		$457K Buy
228,600
+63,500
+38% +$175K ﹤0.01% 1372
2019
Q4 		$570K Hold
165,100
– – ﹤0.01% 1399
2019
Q3 		$473K Buy
165,100
+12,500
+8% +$38.9K ﹤0.01% 1343
2019
Q2 		$578K Buy
152,600
+3,400
+2% +$20.5K ﹤0.01% 1286
2019
Q1 		$1.21M Buy
149,200
+36,700
+33% +$314K ﹤0.01% 1104
2018
Q4 		$908K Buy
112,500
+12,200
+12% +$94.9K ﹤0.01% 1157
2018
Q3 		$765K Hold
100,300
– – ﹤0.01% 1289
2018
Q2 		$575K Buy
100,300
+44,300
+79% +$244K ﹤0.01% 1326
2018
Q1 		$267K Hold
56,000
– – ﹤0.01% 1377
2017
Q4 		$275K Hold
56,000
– – ﹤0.01% 1367
2017
Q3 		$293K Hold
56,000
– – ﹤0.01% 1374
2017
Q2 		$311K Buy
+56,000
New +$341K ﹤0.01% 1362

Other funds holding BCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

State of Wisconsin Investment Board's BCRX Position: Q1 2026 in Review

State of Wisconsin Investment Board reduced its BioCryst Pharmaceuticals (BCRX) stake by 20% in Q1 2026, selling an estimated $529K and leaving 279,064 shares worth $2.66M. The position accounts for 0.01% of the portfolio, ranked #1296.

State of Wisconsin Investment Board first reported a position in BCRX in Q2 2017 and has held it in 36 quarters since. The position peaked at $4.11M in Q2 2021. 301 funds tracked by Wall St. Rank hold BCRX as of Q1 2026.

  • State of Wisconsin Investment Board held 279,064 shares of BioCryst Pharmaceuticals worth $2.66M as of Q1 2026.
  • State of Wisconsin Investment Board sold 68,126 BioCryst Pharmaceuticals shares in Q1 2026, an estimated $529K.
  • BioCryst Pharmaceuticals made up 0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #1296 holding.
  • State of Wisconsin Investment Board first reported a position in BioCryst Pharmaceuticals in Q2 2017 and has held it in 36 quarters since.
  • State of Wisconsin Investment Board's BioCryst Pharmaceuticals position peaked at $4.11M in Q2 2021.
  • 301 funds tracked by Wall St. Rank held BioCryst Pharmaceuticals as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.